Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001387896 | SCV001588636 | pathogenic | Neuropathy, hereditary sensory and autonomic, type 2A; Generalized epilepsy with febrile seizures plus, type 7 | 2020-07-15 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 25-27 of the SCN9A gene. The 5' boundary is likely confined to intron 24. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation. This variant has not been reported in the literature in individuals with SCN9A-related conditions. This variant disrupts the C-terminus of the SCN9A protein. Other variant(s) that disrupt this region (p.Glu1773Glyfs*14) have been determined to be pathogenic (PMID: 25253744). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. |